L-glutamate is one the most important excitatory neurotransmitter at central nervous system level and it is implicated in several pathologies. So, it is very important to monitor its variations, in real time in animal models' brain. Amperometric biosensors have been used because of their very high temporal and spatial resolution, and because suitable for a short to mid-term implantation. The present study aimed to develop and characterize a new glutamate biosensor design that exploits the selectivity of Glutamate Oxidase (GluOx) for l-glutamate, and the capability of a small molecule as propylene glycol (PG) to influence and extend the stability and the activity of enzyme. Different designs were evaluated by modifying the main components in their concentrations to find the most suitable design. Moreover, enzyme concentrations from 100 U/ml up to 200 U/ml were verified and different PG concentrations (1%, 0.1% and 0.05%) were tested. The most suitable selected design was Ptc/PPD/PEI(1%)2/GlutOx5/PG(0.1%) and it was compared to the same already described design loading PEDGE, instead of PG, in terms of over-time performances. PG has proved to be capable of determining an over-time stability of the glutamate biosensor in particular in terms of linear region slope (LRS) up to 21 days.
The most widely used technique for in vivo glutamate monitoring was undoubtedly microdialysis [10] [11] [12] [13] [14] but electrochemical biosensors have been used for many years because of the minimal invasiveness, the rapid and real-time quantification of the studied analytes [15] [16] [17] .
In addition to the previous characteristics, the biosensors, in particular in case of glutamate, require a high sensitivity in monitoring because of the glutamate low concentrations detected in the brain, assessed being in the range of 1-10 µM, and that can be dependent on the brain region of implantation [1] .
One of the open challenges in biosensing is, without a doubt, the real-time glutamate monitoring in CNS in the presence of high levels of electrochemical interferents. Actually, the specificity of amperometric biosensors can be affected by interfering compounds is present in high concentration as in case for ascorbic acid (AA) at CNS level [18, 19] . This is the case that occurs during the monitoring of glutamate that is found, in physiological conditions, at rather low concentrations [1] .
So, because their very high temporal and spatial resolution, implantable amperometric biosensors have proved to be suitable for the implantation, from short to mid-term period, in brain tissues of animal models.
Amperometric biosensors exploit the capability of the biocomponent, usually represented by an enzyme, to specifically bind the studied analyte [17, 20] and to generate some electroactive compound, converting a biological signal into a measurable electrical signal [21] .
In this work, a biosensor design has been developed and characterized for the detection of glutamate, exploiting the capability of L-glutamate oxidase (GluOx) enzyme to convert L-glutamate as follows: L-Glutamate + H2O + GluOx/FAD α -ketoglutarate + NH3 + GluOx/FADH2 (1) GluOx/FADH2 + O2 GluOx/FAD + H2O2 (2)
The hydrogen peroxide (H2O2), produced by the enzymatic reaction, can be easily amperometrically measured at a Pt surface by applying a high fixed anodic potential of +0.7 V vs Ag/AgCl [22] [23] [24] .
In the past, it has been highlighted that the presence of an enzymatic stabilizer as polyethileneimine (PEI) is of fundamental importance for increasing the analytical performances of glutamate biosensor [1, 23, 25] . In this work, the impact of the use of PEI it will be also evaluated.
Moreover, this work will be focused on the entrapment strategies needed to block all the layered biosensor components in order to ameliorate over-time performances of glutamate biosensor, both for an eventual acute and mid-term implant.
In the past, lots of approaches have been adopted to entrap enzyme molecules on the biosensor transducer surface such as covalent coupling, physical adsorption, gel entrapment or crosslinking [17, 26] .
About crosslinking strategy, the most commonly used for the immobilization of enzymes are polymeric films deposited on top of layered components [27] [28] [29] [30] [31] or glutaraldehyde crosslink [32] [33] [34] [35] .
Poly-(ethylene glycol) diglycidyl ether (PEGDE) as crosslinking agent has been proposed in the past [4] and also recently it has been used, resulting a more suitable crosslinker compared with glutaraldehyde for the immobilization of glutamate oxidase and capable to determine better biosensor sensitivities [1, [35] [36] [37] . It has been demonstrated the epoxide groups present in PEGDE molecule can interact with amino groups allowing the cross-linking with the enzyme and also the covalent bonding of the enzyme layer to the surface [38] .
In the past, some papers demonstrated that some compounds as amino acids, methylamines, sugars and polyols, among them propylene glycol, could act as protein stabilizers because of the hydrophobic interaction with protein molecules and because of the protection of enzyme activity [39] [40] [41] [42] [43] . Among all polyols, in the present paper special attention has been given to propylene glycol (PG) that is a nontoxic compound commonly used in the pharmaceutical products as a solvent or stabilizer for many compounds. In the present study it has been evaluated the role of propylene glycol as enzyme stabilizer and containment network of the layered components constituting the biosensors and its impact on kinetic and analytical parameters but also on the stability overtime of the proposed glutamate biosensor design. Propylene glycol biosensors design has been then compared to equivalent but with PEGDE.
Materials and Methods

Chemicals and Reagents
All chemical compounds were bought from Sigma-Aldrich and used as supplied.
The phosphate-buffered saline (PBS, 50 mM) solution used for calibrations and electropolymerisations was made using 0.15 M NaCl, 0.05 M NaH2PO4 and 0.04 M NaOH, and adjusted to pH 7.4.
Sodium glutamate (Glut, 1 M and 10 mM), PG, PEGDE (0.1%), polyethyleneimmine (PEI, 1%)
solutions were diluted in bidistilled water, while o-phenylenediamine (OPD) was prepared in fresh PBS. Stock solutions of ascorbic acid (AA, 100 mM) were prepared in HCL 0.01 N and stored at -20 °C.
Glutamate Oxidase (GluOx, Streptomyces sp., EC 1.4.3.11, 200 U/ml) was from Yamasa Corp. 
Biosensor construction and characterisation
As shown in Figure 1 , different biosensor designs were developed, all of them based on a cylindrical geometry (1 mm length and 125 μm diameter).
Biosensors were manufactured as previously described [1, 23, 24] and realizing different strategies differentiating biosensor designs, varying components concentrations and processes, to obtain the most performing.
Briefly, a 3 cm portion of Pt wire was cut and from one edge, 3 mm of insulation was eliminated in order to allow bare metal to be welded to its support. From the other edge of the wire, a 1 mm of bare metal was exposed for modifications. On Day 1 a full glutamate calibration, ranging between 0 and 100 mM, was carried out in fresh PBS by the addition of known volumes of the Glut stock solutions (1 M and 10 mM). On same day an AA calibration ranging from 0 to 1000 µM was performed to assess the design capability to block currents from interfering compounds. For all designs, the same calibrations' protocol was repeated on Day 7, and for some of them appropriately selected, also at Day 10, 15 and 21 to assess biosensor ageing.
Different designs have been manufactured (Figure 1 ): the basic design (D1) involved the deposition of all the components previously described except the PEI. A second design (D2) was made by the deposition of all components and above all PG (0.1%). Starting from D2 design, some variations on GluOx and PG concentrations were performed and characterized. A third design (D3) was built by depositing above all layered components PEGDE (0.1%). Biosensor performances were evaluated from calibration data in terms of enzymatic kinetic (VMAX and KM) and analytical performances (linear region slope -LRS, AA blocking).
All designs were tested for currents due to the main interfering compounds as DA, DOPAC, UA, 5-HIAA. In all cases, the above-mentioned compounds did not determine any interfering signal on biosensor glutamate monitoring, as previously showed [44] . 
Statistical analysis
After calibrations, biosensor currents were plotted versus Glut and AA concentrations. First, for glutamate data a nonlinear fitting with Michaelis-Menten equation was performed on the entire concentration range (0-100 mM) to evaluate VMAX and apparent KM. Linear regressions (slope) were calculated at low concentrations (0-0.6 mM). Recorded currents were given in nanoamperes (nA) and expressed as baseline-subtracted values ± standard error of the mean.
AA shielding was evaluated by taking in account the current recorded at 500 µM and ΔI value, which stands for the difference between the current resulting from the injection of 1000 µM and 500 µM of AA in the electrochemical cell, as discussed previously [45] .
Statistical significance (P values) between groups was assessed using unpaired t-tests by GraphPad Prism 5.02 v software.
Results and discussion
In Vitro performances of glutamate biosensors
As shown in Figure 2 and From these results, it is evident that the presence of PEI in the biosensor design is fundamental in order to increase the enzymatic activity and make the biosensor more performing, as previously demonstrated [23, 25] . In fact, the polycation PEI has been demonstrated to be able to stabilize different enzymes because of the reduction of the repulsion between anionic charges on GluOx molecules, determining a better biosensor efficiency [23, 25] . Therefore, at Day 7, it occurred a decrease in VMAX (-2.5%) and AA shielding (+76 % of AA current)
and LRS (about -8%) and an increase in KM (+9.7%), demonstrating a general over-time worsening if compared with D2 design.
The crosslinker PEGDE has been largely used in biosensor fabrications and in particular for glutamate biosensors [1, [35] [36] [37] . Our results, in the considered range of time, confirm the capability of PEGDE to avoid the loss of substrate specificity, that can occur during enzyme immobilization. This phenomenon is due to its mild action towards the enzyme molecules, due to its epoxy moiety on enzyme amino groups, thus saving enzyme conformation [37] . 
Effects of the difference of enzyme concentration in glutamate biosensor parameters
In the present study different concentrations of enzyme were used. As displayed in Figure 3 By increasing the concentration of the enzyme up to 150 U/ml (blue curve) the observed parameters at Day 1 were 232.81 ± 5.65 nA and 508.54 ± 59.54 µM (R 2 =0.997) and 0.237 ± 0.002 nA/µM for VMAX, KM and LRS respectively. The AA shielding resulted similar to that obtained for the design loading 100 U/ml (data not shown). Even for the latter design, at Day 7 occurred an improvement in performances: VMAX and LRS decreased of about 15% and 17% respectively, KM did not undergo any substantial variation, while AA shielding suffered a worsening comparable to the one obtained for the design loading 100 U/ml (data not shown).
From these results, it is clear that enzymatic loading influences the biosensor response. As expected, at Day 1, the decreasing in enzyme loading determined a variation in kinetic and analytic parameters.
In fact, as previously demonstrated [28, 29, 46] 200U/ml design it decreased, in 150 U/ml design it increased and in 100 U/ml design it remained almost the same. U/ml; red curve: 100 U/ml.
Effects of the variation of propylene glycol in glutamate biosensor performances
As shown in Fig 4, AA shielding suffered a slight worsening (data not shown).
When PG was halved (black curve), that was 0.05%, the design displayed a VMAX= 225.52 ± 6.23
nA, a KM= 369.86 ± 49.60 µM (R 2 =0.995) and a LRS= 0.290 ± 0,012 nA/µM. For this design, the response to AA 500 µM was 1,363 ± 0,086 nA and the ΔI was 0.221 nA. At Day 7, if compared to Day 1 performance, the global functioning of this design suffered a worsening about VMAX (about -90%) and LRS (about -93%), while KM underwent the most significant variation reaching 4091.11±
1598.01 µM, determining a substantial affinity loss of the substrate for the enzyme, also AA shielding suffered a worsening, in fact AA 500 µM gave 1,984 ± 0,079 nA and the ΔI was 0.335 nA. The global worsening of the above-mentioned design was also confirmed even if compared with the design loading PG 0.1%.
From these results it was possible to deduce that both halving and decupling enzyme concentration did not produce the best conditions for biosensor monitoring. In fact a global worsening for all parameters was observed. So, the concentration of 0.1% was chosen to study the behavior of the biosensor over a period of 21 days. 
Effects of PG or PEGDE on glutamate biosensor ageing
Following the interesting results, the ageing of two selected designs was evaluated. The chosen designs were the one loading PG (0.1%) and the other loading PEGDE (0.1%). As shown in Fig 5, The use of PEDGE in glutamate biosensors have been widely described, its capability to stabilize enzyme molecules as well [1, 4, [35] [36] [37] . It has been shown that the cross-linking between PEGDE molecules and the enzyme is favored by the presence of the epoxide groups, whom can interact with amino groups allowing the covalent bonding of the enzyme layer to the surface [38] . In the present study, we have demonstrated that glutamate biosensors loading PEDGE (0.1%) show very good analytical performances over the period of 21 days as previously described [1] , as well as the design loading PG (0.1%). Although, PEGDE showed quite interesting values in terms of VMAX, KM and LRS, PG design showed a very fascinating behavior over time. In fact, VMAX values had an upward trend up to Day 15, indicating that the number of active molecules on the transducer surface was formally increased during the days. Conversely, in the PEGDE design, after a certain stability between day 1 and day 7, VMAX showed a tendency to decrease over time, denoting a loss in the number of active molecules.
On the other hand, KM behavior was, more or less, comparable between both designs. In fact, in both cases a general increase over time was achieved, as expected.
The changes in these parameters were reflected in the LRS parameter, which proved to be very interesting.
Nevertheless, although PEGDE design revealed higher values of LRS, showing a relatively-better efficiency in monitoring glutamate, but with a tendency to decrease over time, the PG design resulted in a sustained stability over a period of 15 days. In both cases, after 21 day efficiency began to change significantly.
Thus, in the present study it has been highlighted that the presence of PG it turned out to be very important for glutamate biosensor stability over time. In literature, it has been widely demonstrated the capability of molecules like propylene glycol, what polyols are, to stabilize proteins and further their long-term stability: in fact, the presence of polyols reduces the unfavorable interaction present between the solution and the proteins [47] . It has been also demonstrated that stabilizing osmolytes, as propylene glycol is, are able to move the equilibrium of proteins from denaturation to the native conformation, leading to the stabilization of the protein itself [48] . Thus, the presence of the osmolytes can change the amount of water near the protein during the reactions, determining changes also in its stability [49] . In the present study, it seems that PG has been able to interact with the proteins molecules by determining an improvement of their conformational state and producing an increase of the active molecules on the transducer surface and favoring the stability over time. 
Conclusions
In the present study, the role of PG has been evaluated. From results it is possible to affirm that PG helps avoiding the loss of active molecules on transducer surface but also to preserve substrate specificity, making the proposed biosensor design suitable for short-and mid-term implants in animal models.
At the moment, some experiments are underway to evaluate the role of PG on other biosensor, as glucose and lactate biosensors.
